RCMNY
VIRX

Rubric Capital Management (New York)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Rubric Capital Management (New York)’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,487,385
Closed -$2.36M – 76
2023
Q1 		$2.36M Buy
1,487,385
+156,402
+12% +$249K 0.06% 66
2022
Q4 		$1.94M Buy
1,330,983
+336,182
+34% +$491K 0.08% 84
2022
Q3 		$4.25M Buy
+994,801
New +$4.25M 0.21% 66